Cerexa is a biopharmaceutical company produces a portfolio of anti-infective therapies for the treatment of life-threatening infections. Founded by Dennis Podlesak and James Ge in 2005, Cerexa . is backed by investors that include Canaan Partners, Domain Associates, Frazier Healthcare Partners, New Leaf Venture Partners, and OrbiMed and is headquartered in New York.